PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Blue Cross & Blue Shield of MississippiAll Plans · Coverage · Medical Policy · Radiation Oncology, OncologyMedium impact

Charged-Particle (Proton or Helium Ion) Radiotherapy for Neoplastic Conditions

Effective date
Not stated in the notice
Identified
Jun 20, 2026

Summary

Charged-particle irradiation with proton or helium ion beams may be considered medically necessary for primary therapy of uveal tract melanoma meeting the listed size and metastasis criteria, for postoperative therapy after biopsy or partial resection of skull-base chordoma, low-grade chondrosarcoma or cervical spine lesions with residual localized tumor, and for pediatric central nervous system tumors. It may also be considered medically necessary where photon-based radiotherapy cannot meet normal tissue dose-volume constraints, including curative treatment of primary or benign solid pediatric non-CNS tumors such as Ewing sarcoma, nonmetastatic primary non-small cell lung cancer, and head and neck cancers. Clinically localized prostate cancer and non-curative treatment of these pediatric tumors and non-small cell lung cancer are considered investigational.

Get alerts when payers change rules like this one

We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.

Get Blue Cross & Blue Shield of Mississippi alertsPolicy Monitoring is free. No card required.

What to do

Action · 5 steps
01Check current applicability before acting on this policy.
02Billing team: for the photon dose-constraint indications, attach clinical documentation based on dosimetry plans showing that conventional or advanced photon-based radiotherapy (IMRT, VMAT, SRS or SBRT) would exceed tolerance doses to the structures at risk.
03For individuals with NF-1 or retinoblastoma, attach clinical documentation of the condition to show increased risk from radiation exposure.
04BCBSMS makes no payment for services not documented to be Medically Necessary.
05Clinically localized prostate cancer is considered investigational under this policy.

Codes mentioned

77520775227752377525773997729977499C41.0C41.2C40.80C40.82C40.90C40.92C41.9C69.30C69.32C79.51C79.52D8004ZZD0014ZZD0064ZZ

Original notice

Charged-Particle (Proton or Helium Ion) Radiotherapy for Neoplastic Conditions
bcbsms.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account